Aerotel Medical System Form an Alliance with Italian Leading Telemedicine Services Provider Telbios

TelbiosTelbios, the leading telemedicine services provider in Italy, has signed an exclusivity agreement with Aerotel Medical System, world leader in manufacturing of medical devices and software platforms for telemedicine and Home Care services, for exclusive marketing and distribution of Aerotel innovative products in the Italian market.

AerotelThe agreement with Aerotel expands the range of telemedicine and home care services offered by Telbios, which includes Tele-assistance, Tele-cardiology, and Tele-radiology services. Health organizations such as hospitals, private and public healthcare institutions can now offer their patients a simple and efficient means to monitor the state of their health.

"The agreement with Aerotel is important since it gives us access to devices and technologies that are state of the art and that complete Telbios’s range of services offered," says Leopold Genovesi, CEO of Telbios.

Aerotel's devices such as EKG machines allow the patients to self measure the cardiologic parameters and send them, in short time, via telephone or GSM mobile phone handset, from any location to the call center. The transmitted information can be instantly interpreted by the team of cardiologists of San Raffaele Scientific Institute in Milan working within Telbios Telemedicine Service Center on a 24 hours call basis and immediately sent to the attending GP of the patient.

"Thanks to this technology the chronically ill patients can now avail of those technologies and are offered the possibility to be monitored without leaving the comfort of their home or while travelling and still follow a tight treatment protocol that results in the benefit of their quality of life," conclude Genovesi.

"Telemedicine is a growing market all over the globe and in Italy we can also see a very positive growth," says David Rubin, President & CEO of Aerotel Medical Systems."Having Telbios as a business partner will allow us both to develop dedicated solutions to the growing Italian market."

Monitoring the chronically ill patients can be considered as an emergency on a national level: in Italy there are over 2.5 million diabetic patients, over 4 million patients suffering for respiratory dysfunction, one million of patients suffering form chronic heart failure and the number of patients under anticoagulation treatment exceeds one million. Patients with two or more chronic diseases are the 19.4% of the population.

Telemedicine is the most suitable remote follow up method for the cited pathologies. Telemedicine reduces the unnecessary hospitalizations and reduces waiting lists for medical treatment with a significant saving factor on economical resources.

TELBIOS S.p.A.
Ufficio Stampa
Danilo Magliano
Tel .: +39 02 26433759
Mobile: +39 3357 563583
Web: www.telbios.it
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerotel
Hazoref st. 5, Holon 58856, Israel
Tel.: +972 3 559 3222
Fax: +972 3 559 6111
Web: www.aerotel.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Telbios
Telbios is the Italian company leader for Telemedicine services and networks in civil and military health care structures, and for Home Care assistance, proposing services and customer oriented solutions.

Telbios features his services thanks to the assistance supplied by Telemedicine Service Center (TSC) where 24 h a day technic specialist operators and specialist phisicians are on hand for customer clinic data and diagnostic images recipt, management, archiving, monitoring and reporting. CST ensures a protect data access to information about single patient and enables the web clinic data sharing, with emergency intervention activity at every time.
For more information about Telbios, please visit Telbios website at www.telbios.com

About Aerotel Medical Systems
Aerotel Medical Systems is a world leader in cost-effective, high quality, user-friendly, medical diagnostic systems and devices for the home care, eHealth and Telemedicine markets. The company provides a complete disease management package, including transtelephonic Portable devices designed for a variety of remote diagnostic, and monitoring applications; a hardware and software platform; plus phone and web-based software.

Established in 1985, Aerotel has implemented its solutions in the USA, Europe, India, China, Australia, South America and many other countries worldwide.Frost & Sullivan has recently named Aerotel as "Company of the year" for the European telemedicine market. Aerotel products are CE marked and FDA cleared for marketing in the US with the intention to be used by patients themselves. They are designed for simple use and are famous for their quality and reliability.
For more information about Aerotel, please visit Aerotel website at www.aerotel.com

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...